Philogen announces its attendance at the 12th Annual World ADC London 2022.
Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Pan-tumoral Small Molecule-Drug Conjugates targeting Fibroblast Activation Protein in solid lesions”.
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Modulating the Therapeutic Activity of ADCs & SMDCs With Engineered Cytokine Products”.
Please follow the link below for more information